Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ahter Tanay Tayyar, Ahmet Tayyar, Sukran Kozali, Resul Karakus, Seren Karakus, Ilkbal Temel Yuksel, Ismail Dag, Gonca Yetkin Yildirim & Oya Demirci. (2019) Maternal cytoglobin (CYGB) serum levels in normal and preeclamptic pregnancies. The Journal of Maternal-Fetal & Neonatal Medicine 32:11, pages 1859-1863.
Read now
Read now
Sara Ornaghi & Michael J Paidas. (2014) Upcoming drugs for the treatment of preeclampsia in pregnant women. Expert Review of Clinical Pharmacology 7:5, pages 599-603.
Read now
Read now
Articles from other publishers (16)
Claire Richards, Kimberly Sesperez, Michael Chhor, Sahar Ghorbanpour, Claire Rennie, Clara Liu Chung Ming, Chris Evenhuis, Valentina Nikolic, Natasa Karadzov Orlic, Zeljko Mikovic, Milan Stefanovic, Zoran Cakic, Kristine McGrath, Carmine Gentile, Kristen Bubb & Lana McClements. (2021) Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia. Biology of Sex Differences 12:1.
Crossref
Crossref
Anna L. David. (2021) Ethical and Regulatory Considerations of Placental Therapeutics. Clinical Therapeutics 43:2, pages 297-307.
Crossref
Crossref
Ella Rorman, Amir Freud, Tamar Wainstock & Eyal Sheiner. (2020) Maternal preeclampsia and long-term infectious morbidity in the offspring – A population based cohort analysis. Pregnancy Hypertension 21, pages 30-34.
Crossref
Crossref
O. Z. Yaremchuk, K. A. Posokhova, І. P. Kuzmak, M. I. Kulitska, I. М. Klishch & M. M. Korda. (2020) Indexes of nitric oxide system in experimental antiphospholipid syndrome. The Ukrainian Biochemical Journal 92:1, pages 75-83.
Crossref
Crossref
R Spencer, C Rossi, M Lees, D Peebles, P Brocklehurst, J Martin, SR Hansson, K Hecher, K Marsal, F Figueras, E Gratacos & AL David. (2019) Achieving orphan designation for placental insufficiency: annual incidence estimations in Europe. BJOG: An International Journal of Obstetrics & Gynaecology 126:9, pages 1157-1167.
Crossref
Crossref
Anne Brandolt Larré, Fernando Sontag, Débora Montenegro Pasin, Nathália Paludo, Rayssa Ruszkowski do Amaral, Bartira Ercília Pinheiro da Costa & Carlos Eduardo Poli-de-Figueiredo. (2018) Phosphodiesterase Inhibition in the Treatment of Preeclampsia: What Is New?. Current Hypertension Reports 20:10.
Crossref
Crossref
Vasiliki Katsi, Georgios Georgountzos, Manolis S. Kallistratos, Ioannis Zerdes, Thomas Makris, Athanasios J. Manolis, Petros Nihoyannopoulos & Dimitris Tousoulis. (2017) The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?. Frontiers in Pharmacology 8.
Crossref
Crossref
Thomas R. Everett, Ian B. Wilkinson & Christoph C. Lees. (2017) Pre-eclampsia: the Potential of GSNO Reductase Inhibitors. Current Hypertension Reports 19:3.
Crossref
Crossref
Douglas B. Kell & Louise C. Kenny. (2016) A Dormant Microbial Component in the Development of Preeclampsia. Frontiers in Medicine 3.
Crossref
Crossref
E.R. Barnea, F. Vialard, H. Moindjie, S. Ornaghi, M.N. Dieudonne & M.J. Paidas. (2016) PreImplantation Factor (PIF*) endogenously prevents preeclampsia: Promotes trophoblast invasion and reduces oxidative stress. Journal of Reproductive Immunology 114, pages 58-64.
Crossref
Crossref
Ben W J Mol, Claire T Roberts, Shakila Thangaratinam, Laura A Magee, Christianne J M de Groot & G Justus Hofmeyr. (2016) Pre-eclampsia. The Lancet 387:10022, pages 999-1011.
Crossref
Crossref
Sara Ornaghi, Martin Mueller, Eytan R. Barnea & Michael J. Paidas. (2015) Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus-harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis. Birth Defects Research Part C: Embryo Today: Reviews 105:3, pages 209-225.
Crossref
Crossref
Thomas R. Everett, Ian B. Wilkinson, Amita A. Mahendru, Carmel M. McEniery, Stephen F. Garner, Alison H. Goodall & Christoph C. Lees. (2014)
S
-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia
. British Journal of Clinical Pharmacology 78:3, pages 660-669.
Crossref
Crossref
Tamanrit Johal, Christoph C. Lees, Thomas R. Everett & Ian B. Wilkinson. (2014) The nitric oxide pathway and possible therapeutic options in pre-eclampsia. British Journal of Clinical Pharmacology 78:2, pages 244-257.
Crossref
Crossref
R. N. Spencer, D. J. Carr & A. L. David. (2014) Treatment of poor placentation and the prevention of associated adverse outcomes - what does the future hold?. Prenatal Diagnosis 34:7, pages 677-684.
Crossref
Crossref
John W. Downing, Curtis L. Baysinger, Raymond F. Johnson & Ray L. Paschall. (2013) Review: Potential druggable targets for the treatment of early onset preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 3:4, pages 203-210.
Crossref
Crossref